Reginald J. Sanders - 08 Jan 2025 Form 4 Insider Report for EyePoint Pharmaceuticals, Inc. (EYPT)

Role
Director
Signature
/s/ Ron Honig, Attorney-in-Fact
Issuer symbol
EYPT
Transactions as of
08 Jan 2025
Net transactions value
$0
Form type
4
Filing time
08 Jan 2025, 16:14:00 UTC
Next filing
06 Jan 2026
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EYPT Stock Options (Right to buy) Award $0 +80,000 $0.000000 80,000 08 Jan 2025 Common Stock 80,000 $9.11 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option becomes exercisable in three ratable annual installments beginning on January 8, 2026.